TRS(TRS)
TRS
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $676M | $705M |
| Low | $675M | $705M |
| High | $677M | $705M |
| EBITDA Avg | $102M | $107M |
| Low | $102M | $107M |
| High | $102M | $107M |
| EBIT Avg | $51M | $53M |
| Low | $51M | $53M |
| High | $51M | $53M |
| Net Income Avg | $68M | $90M |
| Low | $68M | $89M |
| High | $68M | $90M |
| EPS Avg | $1.66 | $2.20 |
| Low | $1.66 | $2.19 |
| High | $1.67 | $2.21 |
| Analysts (Rev / EPS) | 2 / 2 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $174M | $159M | $175M | $184M | $180M | $167M |
| Low | $172M | $156M | $172M | $181M | $177M | $165M |
| High | $175M | $162M | $177M | $186M | $182M | $170M |
| EBITDA Avg | $26M | $24M | $26M | $28M | $27M | $25M |
| Low | $26M | $24M | $26M | $27M | $27M | $25M |
| High | $26M | $24M | $27M | $28M | $28M | $26M |
| EBIT Avg | $13M | $12M | $13M | $14M | $14M | $13M |
| Low | $13M | $12M | $13M | $14M | $13M | $12M |
| High | $13M | $12M | $13M | $14M | $14M | $13M |
| Net Income Avg | $18M | $15M | $18M | $21M | $21M | $20M |
| Low | $18M | $14M | $18M | $20M | $21M | $19M |
| High | $19M | $16M | $19M | $21M | $21M | $20M |
| EPS Avg | $0.50 | $0.41 | $0.51 | $0.57 | $0.58 | $0.54 |
| Low | $0.49 | $0.38 | $0.50 | $0.56 | $0.57 | $0.53 |
| High | $0.52 | $0.45 | $0.52 | $0.58 | $0.59 | $0.55 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |